Target intelligence / Profile preview

Glucosyltransferase B (GtfB)

Target
GtfB
Molecular classification
Enzyme, Glycoside hydrolase family 70, Glycosyltransferase
01

Overview

Glucosyltransferase B (GtfB) is an extracellular enzyme secreted by the cariogenic bacterium Streptococcus mutans, which plays a pivotal role in the pathogenesis of dental caries. GtfB catalyzes the cleavage of dietary sucrose to synthesize water-insoluble glucans (primarily containing alpha-1,3-glucosidic linkages) that form the structural scaffold of the dental plaque biofilm. This insoluble extracellular polysaccharide matrix promotes the adherence and accumulation of S. mutans and other acidogenic microorganisms on the tooth surface, creating a protected, acidic microenvironment that leads to enamel demineralization. GtfB also mediates cross-kingdom interactions by binding to the cell wall mannans of Candida albicans, further enhancing biofilm stability and virulence. As a therapeutic target, GtfB is highly attractive because inhibiting its activity impairs biofilm formation and bacterial virulence without killing the bacteria, thereby minimizing selective pressure for drug resistance and preserving the commensal oral microbiota. Various natural polyphenols (such as apigenin and epigallocatechin gallate), small-molecule inhibitors (like G43), and repurposed drugs (such as radotinib and pranlukast) are being investigated for their ability to target GtfB and prevent dental caries.

Other names
GtfBGTF-I1,3-alpha-D-glucan synthaseGlucansucrase GtfBWater-insoluble glucan-synthesizing glucosyltransferase B
02

Mechanism of action

Inhibition of glucosyltransferase enzymatic activity to prevent the synthesis of water-insoluble glucans and disrupt biofilm formation.

03

Biological functions

Biofilm formationCarbohydrate metabolismCell adhesionInsoluble glucan synthesis
04

Disease associations

InfectionDental cariesEarly childhood caries
05

Safety considerations

Disruption of oral microbiome commensal speciesLow bioavailability in the oral cavityRapid clearance by salivaPotential cross-reactivity of antibodies with human tissue in vaccine approaches
06

Interacting drugs

7 more in the full profile.

07

Biomarkers

Salivary glucosyltransferase B levelWater-insoluble glucan levelStreptococcus mutans load

Beyond the preview

Go deeper on Glucosyltransferase B (GtfB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucosyltransferase B (GtfB).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call